BREAKING: Spot ETF Application Filed for an Unexpected Altcoin

According to breaking news, Canary has filed an application for a Mog Coin (MOG) Spot ETF.

Mog Coin, a $140 million memecoin, experienced a sudden price movement following this development.

Interestingly, the token is not yet listed on Binance. However, it is available on the spot market on Coinbase, the largest cryptocurrency exchange in the US.

Currently, the MOG price is trading approximately 90% below its all-time high.

*This is not investment advice.*
https://bitcoinethereumnews.com/crypto/breaking-spot-etf-application-filed-for-an-unexpected-altcoin/

3 teams who should consider signing in-form Jacob Duffy at IPL 2026 Auction ft. KKR

**Jacob Duffy: The In-Form Kiwi Paceman On IPL 2026 Auction Radar — 3 Teams Who Should Target Him**

New Zealand bowler Jacob Duffy has been making headlines ahead of the upcoming IPL 2026 auction. The medium pacer starred with the ball in the fifth and final T20I against the West Indies, returning exceptional figures of 4/35 as the Kiwis secured an eight-wicket win on Thursday, November 13. Overall, the 31-year-old bagged 10 wickets to win the Player of the Series award as New Zealand clinched the series 3-1.

The Southland-born cricketer has impressed for the Kiwis in white-ball formats. Duffy has claimed 53 wickets in just 38 T20Is at a tidy economy rate of 7.36, including four four-fers. He’s also delivered in ODIs, scalping 33 wickets in 17 matches at an economy rate of 6.06.

In domestic T20s, Duffy has picked up 178 wickets in 156 games, boasting two five-fors and seven four-wicket hauls. His domestic career further highlights his consistency, with 320 First-Class wickets and 176 List-A wickets to his name.

Despite going unsold at the IPL 2021 auction with a base price of INR 50 lakh, Duffy’s career has flourished since then. Having grown in experience and showcased his match-winning abilities, the Kiwi pacer is now one of the top overseas prospects likely to be snapped up as several franchises look to strengthen their bowling attack at the IPL 2026 mini-auction.

Below, we look at three teams who should seriously consider signing the in-form Jacob Duffy.

### 1. Kolkata Knight Riders (KKR)

Kolkata Knight Riders have been heavily dependent on Anrich Nortje (South Africa) and Harshit Rana (India) among their pace-bowling options. Nortje’s injury after just two games in IPL 2025 was a big setback, though he rebounded with a strong showing (seven wickets for the Dolphins in the CSA T20 Challenge).

Rana emerged as KKR’s second-highest wicket-taker in IPL 2025 with 15 scalps but bowled at a high economy rate of 10.18. Vaibhav Arora, their leading wicket-taker (17 wickets), is still considered a work in progress. Australian pacer Spencer Johnson did not live up to expectations, taking just one wicket in four matches at an economy of 11.73.

Bringing in Jacob Duffy could provide KKR with a solid, experienced overseas pacer — a potential upgrade on Johnson and a much-needed reinforcement for their pace attack.

### 2. Delhi Capitals (DC)

Delhi Capitals, led by Axar Patel, have a fast-bowling unit that’s overly reliant on Australian ace Mitchell Starc. Dushmantha Chameera, their second overseas pacer, proved disappointing in IPL 2025, picking up only four wickets in six matches at an economy of 11.40.

Among Indian bowlers, Mukesh Kumar claimed 12 wickets in as many games but struggled for consistency and finished with a high economy rate of 10.32. Meanwhile, senior pro Mohit Sharma, at 37, managed only two wickets in eight matches at an economy of 10.28—indicative of a decline.

Jacob Duffy’s arrival could give DC the quality and control they need, making him an ideal replacement for Chameera and helping shore up their bowling core.

### 3. SunRisers Hyderabad (SRH)

Like DC, SunRisers Hyderabad are heavily reliant on just one leading fast bowler — their captain, Pat Cummins. Mohammad Shami had a subpar IPL season in 2025, taking six wickets in nine games before picking up an injury, though his recent form suggests improvement heading into next season.

Simarjit Singh struggled, managing just two wickets in four games in IPL 2025. On the brighter side, Jaydev Unadkat impressed with 11 wickets in seven matches, while Eshan Malinga stepped up with 13 wickets from as many games.

Even with Malinga as a promising second seamer, the 2016 champions need depth and overseas backup for Cummins. Jacob Duffy fits that requirement perfectly and could be the key addition they need to bolster their fast-bowling stocks.

**Conclusion**

Jacob Duffy’s strong performances for New Zealand and his consistency in domestic cricket make him a highly attractive option ahead of the IPL 2026 auction. With proven credentials and valuable experience, Duffy has the potential to be a game-changer for any team needing pace bowling reinforcements.

Franchises like Kolkata Knight Riders, Delhi Capitals, and SunRisers Hyderabad would be wise to keep Duffy on their radar as they look to build winning squads for the upcoming season.
https://www.sportskeeda.com/cricket/3-teams-consider-signing-in-form-jacob-duffy-ipl-2026-auction-ft-kkr

Singapore Pioneers Tokenized Government Bonds With CBDC Settlement

**Revolutionary: Singapore Pioneers Tokenized Government Bonds With CBDC Settlement**

Singapore has taken a groundbreaking step by pioneering the issuance of tokenized government bonds settled using Central Bank Digital Currency (CBDC). This innovative approach marks a significant advancement in the integration of blockchain technology within the financial sector.

The adoption of tokenized government bonds allows for enhanced transparency, efficiency, and accessibility in bond issuance and settlement processes. By leveraging CBDC for settlement, Singapore aims to streamline transactions, reduce costs, and increase the overall security of financial operations.

This initiative positions Singapore at the forefront of digital finance innovation, setting a precedent for other countries exploring the benefits of combining traditional financial instruments with digital currencies. Stay tuned for more updates on this revolutionary development in the world of finance.

*Source:* [Insert source link here]
https://bitcoinethereumnews.com/tech/singapore-pioneers-tokenized-government-bonds-with-cbdc-settlement/

FX’s “English Teacher” Cancelled After Two Seasons

**FX Comedy Series “English Teacher” Cancelled After Two Seasons**

The FX comedy series *English Teacher* will not be returning for a third season, as Deadline has revealed the show has been cancelled.

Created by Brian Jordan Alvarez, *English Teacher* stars Alvarez as Evan Marquez, a high school teacher in Austin, Texas. The series follows Evan as he navigates the complex intersection of personal, professional, and political challenges within a high school setting. Throughout the first season, Evan works through his relationships, interactions with students, and dealings with fellow faculty members, while trying to answer the question: can you truly be your full self at your job?

The first season of *English Teacher* premiered in 2024 across FX, Hulu, and Disney+, with the second season arriving on those platforms earlier this year.

**Critical Acclaim and Awards**

*English Teacher*’s first season earned widespread critical praise, receiving three Critics’ Choice Awards nominations including Best Comedy Series. It also garnered four Film Independent Spirit Awards nominations, including Best New Scripted Series, along with two Writers Guild Award nods for New Series and Episodic Comedy.

The show quickly became one of the best-reviewed series of the year. It appeared on numerous critics’ year-end Top 10 lists — notably ranked as the #1 Best Show of the Year by both Decider and Consequence. The first season holds a Certified Fresh score of 98% on Rotten Tomatoes and a Must Watch score of 83 on Metacritic. Its second season achieved an impressive 100% Certified Fresh rating on Rotten Tomatoes.

**Cast and Production**

Alongside Brian Jordan Alvarez, the series stars Stephanie Koenig, Enrico Colantoni, Sean Patton, and Carmen Christopher. Alvarez not only created the show but also served as an executive producer, alongside Paul Simms, Jonathan Krisel, Dave King, Kathryn Dean, Jake Bender, and Zach Dunn.

Both seasons of *English Teacher* are currently available to stream on Hulu and Hulu on Disney+ in the United States, and on Disney+ internationally.

**Looking Ahead**

As with many cancelled shows, if you haven’t yet watched *English Teacher* or want to revisit it, now is the time. Cancelled series are often removed from streaming platforms to cut costs.

**Roger’s Take**

It’s unfortunate that *English Teacher* wasn’t given more time to find its audience, especially since comedy shows often need longer to build momentum. There is speculation that the show’s future was impacted by allegations of sexual assault made last summer by Jon Ebeling — a collaborator of Brian Jordan Alvarez on *The Gay and Wondrous Life of Caleb Gallo*. The warning signs appeared when FX gave minimal promotion to the new season upon its release earlier this year.

What do you think about *English Teacher* being cancelled? Share your thoughts on social media!
https://whatsondisneyplus.com/fxs-english-teacher-cancelled-after-two-seasons/

Jeff Lynne’s ELO Released “Alone In The Universe” 10 Years Ago Today

Ten years ago today, Jeff Lynne’s ELO released their album Alone In The Universe. To celebrate this milestone, we just want to sing along to the timeless music that has captivated fans around the world.

Additionally, don’t miss our exclusive live review of Jeff Lynne’s performance from 2024. Experience the magic of his live show and see why his music continues to resonate with audiences everywhere.

https://magnetmagazine.com/2025/11/13/jeff-lynnes-elo-released-alone-in-the-universe-10-years-ago-today/

XRP Spot ETF Lists On Nasdaq Today Under Ticker XRPC

**XRPC Spot ETF Launches After Nasdaq Certification: Trading Begins Today**

XRPC becomes effective at 5:30 p.m. ET after Nasdaq certification, with trading set to begin today. Recent EDGAR filings reveal the S-1/A filing path and 8-A registration required for the Nasdaq listing. In related news, Canary Funds has added a spot MOG ETF filing, expanding its single-asset digital fund lineup.

**XRPC Becomes First Single-Asset XRP Spot ETF**

The first-ever single-asset XRP spot ETF is scheduled to begin trading after Canary Funds confirmed its effectiveness at 5:30 p.m. ET on Wednesday. Financial journalist Eleanor Terrett reported that Nasdaq certification has cleared XRPC for launch at the U.S. market open on November 13, providing traders with a clear timeline and trading venue.

According to Terrett, the outcome was made possible through actions taken by SEC officials, including Commissioner Hester Peirce and former Commissioner Paul Atkins, both cited in statements regarding the ETF approval process. The newly approved XRPC ETF followed the standard pathway: S-1/A amendments, Nasdaq certification, and Form 8-A 12(b) effectiveness—removing the final administrative barrier to listing. The documented process sets clear expectations for market participants seeking trading access.

**Nasdaq Confirms Filing and Approval Process**

Nasdaq has verified receipt of the Form 8-A 12(b) filing for XRPC, confirming the listing certification, which aligns all paperwork for the November 13 launch once the notice of issuance is posted. The certification and effectiveness sequence closes the administrative gate before the ETF enters the market for first trade.

A letter from the exchange detailed that Nasdaq had approved XRPC for listing and would proceed with registration upon receipt of official notice of issuance. The exchange also indicated support for the issuer’s request for effectiveness under Form 8-A 12(b), paving the way for the ETF’s debut. With certification finalized, Canary Funds has confirmed that XRPC will launch at the market open on November 13, concluding a comprehensive series of steps that involved regulatory coordination, exchange review, and formal registration requirements.

**Canary Extends Product Pipeline With Spot MOG ETF**

Separately, Canary Funds has filed for a spot ETF tied to MOG Coin, marking the first time this meme-based digital asset will be offered within a regulated investment structure. According to the preliminary prospectus, the “Canary MOG ETF” will operate as a trust issuing shares of beneficial interest to be traded on a registered exchange. The fund will hold MOG coins directly to closely track their market price.

ETF analyst James Seyffart publicly highlighted the new submission, noting it as part of Canary’s expanding digital-asset ETF offerings. The sponsor for the MOG trust is Canary Capital Group LLC, which also launched an HBAR-focused ETF earlier this year.

**Related:**
*XRP Price Stays Rangebound as Canary XRP ETF Launch Enters 48-Hour Countdown*
https://bitcoinethereumnews.com/tech/xrp-spot-etf-lists-on-nasdaq-today-under-ticker-xrpc/

SVB Energy’s Vakhshouri on Global Oil Outlook

SVB Energy International Founder and President, Sara Vakhshouri, shares her outlook on the oil market following its largest decline since June. The drop comes amid growing concerns over a supply glut.

She discusses these developments and the potential impact on the industry during an interview on Bloomberg’s Insight with Haslinda Amin. (Source: Bloomberg)
https://www.bloomberg.com/news/videos/2025-11-13/svb-energy-s-vakhshouri-on-global-oil-outlook-video

GLP-1 Receptor Agonist Market 2030 Forecast: A New Era in Diabetes and Obesity Care

The global GLP-1 receptor agonist market was valued at USD 53.46 billion in 2024 and is projected to reach USD 156.71 billion by 2030, expanding at a CAGR of 17.46% from 2025 to 2030. This impressive growth is driven by the launch of new glucagon-like peptide-1 (GLP-1) receptor agonist products, a strong pipeline targeting diabetes and obesity applications, and the high therapeutic efficacy of these drugs.

### Market Drivers

In May 2024, Innovent Biologics announced that its type 2 diabetes drug candidate, mazdutide, outperformed Eli Lilly’s Trulicity (dulaglutide) in a Phase III trial. The study confirmed that mazdutide was superior in glycemic control and delivered multiple cardiometabolic benefits, including weight reduction and improvements in blood lipid levels, liver enzymes, serum uric acid, and blood pressure.

The rising prevalence of obesity and diabetes is a major factor fueling market expansion. Individuals who are overweight or obese face a significantly higher risk of developing type 2 diabetes and cardiovascular diseases. Currently, the growing global obesity rate is considered one of the most serious public health challenges. According to the World Heart Federation, nearly 2.3 billion children and adults worldwide suffer from obesity or overweight conditions. Similarly, the Obesity Action Coalition (OAC) reports that over 90% of individuals with type 2 diabetes are either overweight or obese. This expanding patient base is expected to accelerate demand for GLP-1 receptor agonist therapies globally.

### Advantages of GLP-1 Receptor Agonists

GLP-1 drugs offer distinct advantages over traditional medicines, which, along with rising R&D investments, further propel the market. These therapies have been associated with weight loss or weight neutrality, a critical benefit for diabetic patients since obesity exacerbates the condition. Their appetite-suppressing effects and delayed gastric emptying contribute significantly to effective weight management.

In November 2023, Novo Nordisk announced plans to invest approximately 16 billion Danish kroner (around USD 2.32 billion / €2.14 billion) to develop advanced GLP-1 drugs, highlighting strong industry commitment to innovation and market expansion.

### Key Market Trends & Insights

– **Regional Performance:** North America accounted for 77.72% of the global revenue in 2024, with the U.S. holding the largest market share within the region.
– **Product Segment:** The Ozempic segment dominated the market with a 34.17% share in 2024.
– **Distribution Channels:** Hospital pharmacies led with a 55.09% revenue share in 2024.
– **Applications:** The type 2 diabetes mellitus segment dominated in 2024 and is projected to grow at a CAGR of 17.06% during the forecast period.
– **Route of Administration:** The parenteral segment held the largest share in 2024 and is expected to grow at a CAGR of 17.42% from 2025 to 2030.

### Market Size & Forecast

| Year | Market Size (USD Billion) |
|——-|—————————–|
| 2024 | 53.46 |
| 2030 (Projected) | 156.71 |

– **CAGR (2024-2030):** 17.46%
– **Largest Market (2024):** North America
– **Fastest Growing Region:** Asia Pacific

[Download a free sample PDF of the GLP-1 Receptor Agonist Market Intelligence Study by Grand View Research.]

### Competitive Landscape

Key players operating in the GLP-1 receptor agonist market include AstraZeneca, Sanofi, Novo Nordisk A/S, and Eli Lilly and Company. These companies leverage their extensive customer bases and strong brand equity to maintain high-quality standards and expand market reach. Significant investments in infrastructure enable efficient processing and analysis of large sample volumes. Strategic collaborations with distributors and partner firms further strengthen their market presence.

Emerging players such as Hanmi Pharm. Co., Ltd, Eccogen, and D&D Pharmatech are focusing on securing government funding and institutional support while introducing innovative products to explore untapped growth opportunities.

**Prominent Companies Include:**

– Eli Lilly and Company
– Sanofi
– Novo Nordisk A/S
– AstraZeneca

Explore Horizon Databook, the world’s most comprehensive market intelligence platform by Grand View Research.

### Conclusion

The global GLP-1 receptor agonist market is poised for strong growth, supported by increasing obesity and diabetes prevalence, expanding product pipelines, and rising R&D investments. Technological innovations and strategic collaborations among key industry players are expected to further accelerate the adoption of GLP-1 receptor agonists worldwide.
https://express-press-release.net/news/2025/11/13/1719992

Texans’ Wednesday injury report includes updates on two key starters

The Houston Texans are gearing up for another AFC South battle in Week 11 against the Tennessee Titans on Sunday at Nissan Stadium. A victory would give the back-to-back division champions more ground in the hunt behind the Indianapolis Colts for a potential move back into first place.

Following Wednesday’s practice, several notable starters were either sidelined or limited in drills during the open media session. Quarterback C.J. Stroud (concussion), defensive back Jalen Pitre (concussion), kicker Ka’imi Fairbairn (quad), and defensive end Denico Autry (knee) were among the players who missed practice entirely. However, several of these key players are expected to return, at least at half speed, for Thursday’s practice.

In addition, various other Texans players participated in practice but were limited in the drills.

On the other side, the Tennessee Titans also faced injury challenges this week. Several players missed practice, and many more were limited as they prepare for Sunday’s contest.

Here’s a look at the Wednesday injury reports for both teams:

**Texans Injury Report**
– C.J. Stroud (concussion) – Did not practice
– Jalen Pitre (concussion) – Did not practice
– Ka’imi Fairbairn (quad) – Did not practice
– Denico Autry (knee) – Did not practice
– Others – Limited participation in drills

**Titans Injury Report**
– Multiple players missed or were limited in practice (details TBD)

Kickoff from Nissan Stadium is scheduled for noon CT. Stay tuned for updates as game day approaches!
https://texanswire.usatoday.com/story/sports/nfl/texans/2025/11/12/texans-titans-injury-report-wednesday-cj-stroud-will-anderson/87243265007/

Super Robot Wars Y Is Launching a DLC on November 21, 2025

Pilot Your Mech in Super Robot Wars Y

Bandai Namco’s long-running crossover mecha series continues to expand with Super Robot Wars Y, which is set to receive its first major DLC on November 21. Titled Contract from the Darkness, the new content brings a fresh lineup of playable units and characters drawn from Galaxy Cyclone Braiger, The Big O, and Fuuto PI: The Portrait of Kamen Rider Skull.

Alongside these additions, players can look forward to new area missions that deepen the game’s already rich tactical experience. Those who purchased the Collector’s Edition, Digital Ultimate Edition, Digital Deluxe Edition, or the combined DLC Pack 1 & 2 set will be able to dive into the expansion early, starting November 19.

Bandai Namco has also released a trailer previewing the new content, giving fans a glimpse of the upcoming storylines, battles, and crossover interactions between the featured series.

Free Update for All Players

In addition to the paid DLC, the game will roll out a free update for all players on November 17. This update introduces a new Special Mission titled “Battle Rush”, along with EX Level Pilot Skills that further enhance combat customization.

It also includes the first mission from the DLC, “A Smile on the Street Corner”, ensuring that even players without the expansion will have something new to explore.

Looking Ahead

With its blend of classic anime mecha and strategic gameplay, Super Robot Wars Y continues to build on its legacy of uniting beloved franchises into one massive battlefield. Fans eager for fresh content and challenges will have plenty to look forward to as the next wave of updates arrives in November.

https://cogconnected.com/2025/11/super-robot-wars-y-is-launching-a-dlc-on-november-21-2025/

Exit mobile version